Kite Pharma, Inc. EBITDA Margin 2014-2017 | KITE
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Kite Pharma, Inc. (KITE) over the last 10 years. The current EBITDA margin for Kite Pharma, Inc. as of June 30, 2017 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2017-06-30 | $0.03B | $-0.34B | -1062.50% |
| 2017-03-31 | $0.03B | $-0.31B | -1129.63% |
| 2016-12-31 | $0.02B | $-0.26B | -1186.36% |
| 2016-09-30 | $0.02B | $-0.22B | -981.82% |
| 2016-06-30 | $0.02B | $-0.17B | -850.00% |
| 2016-03-31 | $0.02B | $-0.13B | -673.68% |
| 2015-12-31 | $0.02B | $-0.10B | -582.35% |
